Definition of treatment goals for moderate to severe psoriasis: a European consensus U Mrowietz, K Kragballe, K Reich, P Spuls, CEM Griffiths, A Nast, J Franke, ... Archives of dermatological research 303, 1-10, 2011 | 1117 | 2011 |
Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study P Gisondi, G Tessari, A Conti, S Piaserico, S Schianchi, A Peserico, ... British Journal of Dermatology 157 (1), 68-73, 2007 | 995 | 2007 |
European S3-guidelines on the systemic treatment of psoriasis vulgaris D Pathirana, AD Ormerod, P Saiag, C Smith, PI Spuls, A Nast, J Barker, ... Journal of the European Academy of Dermatology and Venereology 23 (SUPPL. 2 …, 2009 | 972 | 2009 |
Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies F Alinaghi, M Calov, LE Kristensen, DD Gladman, LC Coates, D Jullien, ... Journal of the American Academy of Dermatology 80 (1), 251-265. e19, 2019 | 565 | 2019 |
European S3-guidelines on the systemic treatment of psoriasis vulgaris-update 2015-short version-EDF in cooperation with EADV and IPC A Nast, P Gisondi, AD Ormerod, P Saiag, CH Smith, PI Spuls, ... Journal of the European Academy of Dermatology and Venereology 29 (12), 2277 …, 2015 | 540 | 2015 |
Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator … P Gisondi, M Del Giglio, V Di Francesco, M Zamboni, G Girolomoni The American journal of clinical nutrition 88 (5), 1242-1247, 2008 | 365 | 2008 |
The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis C Albanesi, S Madonna, P Gisondi, G Girolomoni Frontiers in Immunology 9, 386664, 2018 | 356 | 2018 |
Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis P Gisondi, G Targher, G Zoppini, G Girolomoni Journal of hepatology 51 (4), 758-764, 2009 | 355 | 2009 |
Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case–control study P Gisondi, I Tinazzi, G El-Dalati, M Gallo, D Biasi, LM Barbara, ... Annals of the rheumatic diseases 67 (1), 26-30, 2008 | 350 | 2008 |
Psoriasis and the metabolic syndrome P Gisondi, AC Fostini, I Fossà, G Girolomoni, G Targher Clinics in dermatology 36 (1), 21-28, 2018 | 321 | 2018 |
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris–Part 1: treatment and monitoring recommendations A Nast, C Smith, PI Spuls, G Avila Valle, Z Bata‐Csörgö, H Boonen, ... Journal of the European Academy of Dermatology and Venereology 34 (11), 2461 …, 2020 | 282* | 2020 |
Prevalence of symptoms experienced by patients with different clinical types of psoriasis F Sampogna, P Gisondi, CF Melchi, P Amerio, G Girolomoni, D Abeni, ... British Journal of Dermatology 151 (3), 594-599, 2004 | 239 | 2004 |
Anti–tumour necrosis factor‐α therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study P Gisondi, C Cotena, G Tessari, G Girolomoni Journal of the European Academy of Dermatology and Venereology 22 (3), 341-344, 2008 | 215 | 2008 |
Vitamin D status in patients with chronic plaque psoriasis P Gisondi, M Rossini, A Di Cesare, L Idolazzi, S Farina, G Beltrami, ... British Journal of Dermatology 166 (3), 505-510, 2012 | 205 | 2012 |
Plasma homocysteine and folate levels in patients with chronic plaque psoriasis M Malerba, P Gisondi, A Radaeli, R Sala, PG Calzavara Pinton, ... British Journal of Dermatology 155 (6), 1165-1169, 2006 | 205 | 2006 |
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails ZR Ash, I Tinazzi, CC Gallego, C Kwok, C Wilson, M Goodfield, P Gisondi, ... Annals of the Rheumatic Diseases 71 (4), 553-556, 2012 | 204 | 2012 |
Italian guidelines on the systemic treatments of moderate‐to‐severe plaque psoriasis P Gisondi, G Altomare, F Ayala, F Bardazzi, L Bianchi, A Chiricozzi, ... Journal of the European Academy of Dermatology and Venereology 31 (5), 774-790, 2017 | 181 | 2017 |
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study SK Mahil, N Dand, KJ Mason, ZZN Yiu, T Tsakok, F Meynell, B Coker, ... Journal of allergy and clinical immunology 147 (1), 60-71, 2021 | 176 | 2021 |
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis I Tinazzi, S Adami, EM Zanolin, C Caimmi, S Confente, G Girolomoni, ... Rheumatology 51 (11), 2058-2063, 2012 | 175 | 2012 |
Impairment of sexual life in patients with psoriasis F Sampogna, P Gisondi, S Tabolli, D Abeni Dermatology 214 (2), 144-150, 2007 | 170 | 2007 |